Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance

Pharmaphorum

Insilico Medicine has teamed up with SK Biopharmaceuticals on a wide-ranging, $2.5bn partnership to use AI to find neuroimmune drug candidates.

pharminent June 22, 2026 (Last updated: June 22, 2026)

Pharmaphorum

Insilico Medicine has teamed up with SK Biopharmaceuticals on a wide-ranging, $2.5bn partnership to use AI to find neuroimmune drug candidates.

Related Stories